Literature DB >> 16998510

Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Herbert Tilg1, Alexander R Moschen.   

Abstract

There has been much effort recently to define the role of adipocytokines, which are soluble mediators derived mainly from adipocytes (fat cells), in the interaction between adipose tissue, inflammation and immunity. The adipocytokines adiponectin and leptin have emerged as the most abundant adipocyte products, thereby redefining adipose tissue as a key component not only of the endocrine system, but also of the immune system. Indeed, as we discuss here, several adipocytokines have a central role in the regulation of insulin resistance, as well as many aspects of inflammation and immunity. Other adipocytokines, such as visfatin, have only recently been identified. Understanding this rapidly growing family of mainly adipocyte-derived mediators might be of importance in the development of new therapies for obesity-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998510     DOI: 10.1038/nri1937

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  991 in total

Review 1.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

2.  Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy.

Authors:  John R Koethe; Aihua Bian; Ayumi K Shintani; M Sean Boger; Valerie J Mitchell; Husamettin Erdem; Todd Hulgan
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02-02       Impact factor: 2.205

3.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

Review 4.  B cells in cardiac transplants: from clinical questions to experimental models.

Authors:  William M Baldwin; Marc K Halushka; Anna Valujskikh; Robert L Fairchild
Journal:  Semin Immunol       Date:  2011-09-19       Impact factor: 11.130

5.  Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study.

Authors:  Konstantinos N Aronis; Maria T Vamvini; John P Chamberland; Laura L Sweeney; Aoife M Brennan; Faidon Magkos; Christos S Mantzoros
Journal:  Metabolism       Date:  2011-11-09       Impact factor: 8.694

6.  β-cell autoimmunity in overweight non-diabetic youth: any implications?

Authors:  Ingrid M Libman; E Barinas-Mitchell; S Marcovina; F Bacha; T Hannon; H Tfayli; S J Lee; S Bansal; R Robertson; S Arslanian
Journal:  Pediatr Diabetes       Date:  2010-09-07       Impact factor: 4.866

7.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Authors:  Fernanda M Consolim-Colombo; Carine T Sangaleti; Fernando O Costa; Tercio L Morais; Heno F Lopes; Josiane M Motta; Maria C Irigoyen; Luiz A Bortoloto; Carlos Eduardo Rochitte; Yael Tobi Harris; Sanjaya K Satapathy; Peder S Olofsson; Meredith Akerman; Sangeeta S Chavan; Meggan MacKay; Douglas P Barnaby; Martin L Lesser; Jesse Roth; Kevin J Tracey; Valentin A Pavlov
Journal:  JCI Insight       Date:  2017-07-20

Review 8.  Modulation of hepatic steatosis by dietary fatty acids.

Authors:  Alessandra Ferramosca; Vincenzo Zara
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

9.  Association Between Single Nucleotide Polymorphism +276G > T (rs1501299) in ADIPOQ and Endometrial Cancer.

Authors:  Jan Bieńkiewicz; Beata Smolarz; Andrzej Malinowski
Journal:  Pathol Oncol Res       Date:  2015-09-19       Impact factor: 3.201

Review 10.  Inflammation in obesity-related diseases.

Authors:  Robert W O'Rourke
Journal:  Surgery       Date:  2008-10-30       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.